MarkWide Research

Sale!

Sleep Apnea Devices Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Sleep Apnea Devices Market size exceeded USD 6.9 billion in 2021 and is estimated to register over 8.1% CAGR between 2022 and 2028. Surging prevalence of sleep apnea and related co-morbidities along with growing awareness regarding sleep disorders is amongst the major factors stimulating the overall market growth.
Technological advancement is set to propel sleep apnea devices market growth during the forecast period. These advancements in oral appliances, oxygen devices, actigraphy systems have increased the sleep disorders treatment outcome and success rate. Industry players are focusing on research and development activities for developing innovative technologies. For instance, ResMed launched AirMini, the smallest PAP device that is connected to the remote patient monitoring platform of AirView. This device enable patients to see their data on their phones. Hence, the commercialization of such advanced devices will accelerate the market growth over the coming years.
Similarly, the recently introduced lightweight portable sleep apnea products are combined with pressure compensating sensors that can compensate altitude-related drops in atmospheric pressure, thereby increasing its adoption. Such devices are gaining popularity as it is delivering more choice and flexibility for patients. Thus, the use of technology-enabled sleep apnea devices for both diagnostic and treatment purposes in different sleep disorders is anticipated to upsurge significantly in the forthcoming years.

However, lack of adherence to sleep apnea treatment is amongst the major factors hampering the adoption of sleep apnea devices. Positive airway pressure sleep apnea devices are highly recommended for the treatment of different sleep disorders. Despite the high effectiveness of these devices, action efficacy is restricted in several cases attributable to it requiring accurate & regular usage and constant medical supervision. As per the National Center for Biotechnology Information published studies, around 29% – 83% of patients are not adherent with continuous positive airway pressure ventilation.
In the short run, this lack of adherence will be a major factor restricting sleep apnea devices market growth. However, in the long run, it will not have a very significant impact as the manufacturers emphasize making their products technologically advanced and reducing the drawbacks related to their adherence to sleep apnea treatment.
The COVID-19 arose as an unprecedented public health concern that has affected over millions of individuals worldwide causing significant mortalities. The lockdowns were imposed in the majority of the countries to curb the further transmission of SARS-CoV-2. Hospital admissions and facilities were delivered to the COVID patients on a priority basis, with the majority of the other medical procedures on halt.
In the initial 2020, the incidence, as well as the mortality rate due to coronavirus was highest and people preferred to avoid any other treatment procedures at such facilities. Scheduled appointments and the majority of other disease conditions comprising sleep disorders were referred to as non-emergent. Thus, the unprecedented effect of COVID-19 has affected the use of sleep apnea devices in 2020 however, the market gradually risen from second half of 2021 and is expected to grow considerably in the coming years.
However, the use of sleep apnea devices, especially in home care settings was increased during the pandemic period. Heavy patient inflow and rising pressure on healthcare facilities surged the adoption of these devices in home care settings in order to treat sleep disorders efficiently without visiting hospitals. The favourable initiatives employed during COVID-19 have also contributed to the significant product demand. For instance, the American Academy of Sleep Medicine published guidelines associated with the sleep diseases management of individuals infected with coronavirus infection.
Further, in response to COVID-19, treatment of such diseases is being restructured to ensure that patients receive an easy access to sleep facilities and other health care providers with required resources. Thus, the market growth was hampered in the initial phase of 2020; however, the surged demand for home care and favourable initiatives are anticipated to uplift the sleep apnea devices market sales in the coming years positively.

Growing prevalence of sleep apnea and related co-morbidities is expected to fuel the market statistics

The rising prevalence of sleep disorders and related co-morbidities are expected to boost the market revenue significantly. The rapidly growing geriatric population suffering from sleep apnea and associated health conditions have accelerated the demand for sleep disorders diagnosis & treatment that has further propelled the sleep apnea devices market revenue positively.
Sleep disorders comprising obstructive sleep apnea is the most common sleep-related breathing disorder that promotes substantial disease burden. These conditions inflict health care costs and affect the health-associated quality of life. As per the American Sleep Apnea Association (ASAA) data published in 2019, around 22 million people were suffering from sleep apnea in the U.S.
According to the Asian Pacific Society of Respirology Journal 2020, one-seventh of the global adult population, or around 1 billion people, are estimated to have obstructive sleep apnea (OSA). Hence, owing to the above statistics, the rising prevalence of sleep apnea and related co-morbidities is set to increase the demand for sleep apnea devices that will prove beneficial for sleep apnea devices market expansion.

Advent of novel therapeutic sleep apnea devices is projected to propel the overall market size

Based on product, sleep apnea devices market is segmented as therapeutics and diagnostics. The therapeutics segment held a dominant market share in the global sleep apnea devices market and was valued at USD 4,311 million in 2021. The surging prevalence of sleep disorders along with increasing demand for novel therapeutics in sleep apnea management is anticipated to drive the adoption of therapeutic sleep apnea devices.
Moreover, substantial research and development activities by key industry players are expected to provide novel therapeutic devices that would further benefit the market. Such technological advancements are lessening the disadvantages associated with conventional devices.
This further makes them more convenient, efficient, and easy to use with minimum side effects. For instance, Fisher & Paykel Healthcare launched F&P Evora, a novel nasal mask intended for obstructive sleep apnea (OSA) therapeutics. Additionally, the integration of computer-assisted development and manufacturing will offer more innovations in devices that enable more freedom of movement during sleep.

Increasing utilization of sleep apnea devices at home care settings is anticipated to drive the industry landscape

Based on end-use, sleep apnea devices market is segmented as home care settings & individuals and sleep laboratories & hospitals. The home care settings & individuals segment was valued at USD 3,890 million in 2021 and is expected to witness significant growth during the estimation timeframe owing to the surging adoption & launch of user-friendly homecare sleep apnea devices, rising awareness related to home healthcare, etc. As per the research studies published in 2018, around 1/3rd of sleep apnea testing was carried out at the home care settings.
The prominent industry players are also emphasized developing novel sleep apnea devices for their optimum utilization at home care settings. For instance, Itamar Medical announced the U.S. FDA approval for its WatchPAT One, an entirely one-use home sleep apnea test. These tests deliver optimum accuracy and reliability for patients in home care settings. Such product developments are expected to drive the use of sleep apnea devices in home care settings.

Suring incidence of sleep apnea and related co-morbidities in North America is expected to stimulate the regional business landscape

U.S. sleep apnea devices market is anticipated to surpass USD 4,269 million by 2028. This dominant market share is attributable to several factors such as the presence of major industry players, an increase in the number of individuals suffering from sleep apnea and related co-morbidities, etc. As per the Sleep Foundation 2021 data, snoring was estimated to affect 57% of men and 40% of women in the U.S.
Further, as per the Sleep Advisor Organization article 2021, more than 4,700 sleep labs are currently operating in the U.S. Thus, the diagnosis and treatment of sleep disorders have been significantly rising in the U.S. over the past few years. Moreover, the presence of key sleep apnea devices industry players such as Koninklijke Philips N.V., Fisher & Paykel Healthcare, and Nihon Kohden among others in the country are engaged in new product development & commercialization that facilitates industrial expansion in the U.S.

Business growth strategies implemented by major market players will amplify the industry expansion

Some of the major players operating in the sleep apnea devices market are Koninklijke Philips N.V., Fisher & Paykel Healthcare, ResMed Inc., Invacare Corporation, Natus Medical Inc., and Teleflex Inc., among others. Several strategic initiatives such as novel product launches, mergers, acquisitions, strategic collaborations, and geographic expansion to gain competitive advantages are being undertaken. These prominent market players also emphasize on research and development activities that allows in garnering maximum revenue.

Recent industry developments:

  • In January 2021, Itamar Medical acquired technology and assets of Spry Health. This acquisition helped Itamar to leverage Sprys existing technology to bring the device for continuous remote patient monitoring (RPM) of sleep apnea. This strategic move helped the company gain market expansion opportunity in the growing sleep apnea devices market.
  • In August 2020, Nihon Kohden launched polysmith 12 software for their polysomnography devices. This software is a version 12 of the polysmith software that includes more than 40 market-driven features that offer sleep specialists improved workflow, analysis, and outcomes for the patients. This product launch enabled the company to broaden its product portfolio, thereby driving the market share.

Sleep apnea devices market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Product

  • Therapeutics
    • Airway Clearance Systems
    • Adaptive Servo-ventilation (ASV)
    • Positive Airway Pressure (PAP) Device
    • Oral Appliances
    • Oxygen Devices
    • Others
  • Diagnostics
    • Actigraphy Systems
    • Polysomnography (PSG) Device
    • Respiratory Polygraph
    • Sleep Screening Devices

By End-use

  • Home Care Settings & Individuals
  • Sleep Laboratories & Hospitals

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Sleep apnea devices industry 3600 synopsis, 2017 – 2028

2.1.1    Business trends

2.1.2    Product trends

2.1.3    End-use trends

2.1.4    Regional Trends

Chapter 3   Sleep Apnea Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 – 2028 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing prevalence of sleep apnea and related co-morbidities

3.3.1.2    Rising demand for portable, efficient and superior sleep apnea devices

3.3.1.3    Insurance coverage for treatment of sleep apnea and other sleep disorders

3.3.1.4    Growing awareness regarding sleep apnea and other sleep disorders

3.3.1.5    Increasing aging population

3.3.1.6    Product innovation strategy adopted by key industry players

3.3.2    Industry pitfalls & challenges

3.3.2.1    Clinical consequences and economic impact of sleep apnea and related sleep disorders

3.3.2.2    Lack of adherence to sleep apnea treatment

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.6.1    U.S.

3.6.2    Europe

3.7    Reimbursement scenario

3.8    Technology landscape

3.9    Porter’s analysis

3.10    Competitive landscape, 2021

3.10.1    Competitive matrix analysis, 2021

3.11    PESTEL analysis

Chapter 4   Sleep Apnea Devices Market, By Product

4.1    Key segment trends

4.2    Therapeutics

4.2.1    Market size, by region, 2017 – 2028 (USD Million)

4.2.2    Airway clearance systems

4.2.2.1    Market size, by region, 2017 – 2028 (USD Million

4.2.3    Adaptive servo-ventilation (ASV)

4.2.3.1    Market size, by region, 2017 – 2028 (USD Million)

4.2.4    Positive airway pressure (PAP) device

4.2.4.1    Market size, by region, 2017 – 2028 (USD Million)

4.2.5    Oral appliances

4.2.5.1    Market size, by region, 2017 – 2028 (USD Million)

4.2.6    Oxygen devices

4.2.6.1    Market size, by region, 2017 – 2028 (USD Million)

4.2.7    Others

4.2.7.1    Market size, by region, 2017 – 2028 (USD Million)

4.3    Diagnostics

4.3.1    Market size, by region, 2017 – 2028 (USD Million)

4.3.2    Actigraphy systems

4.3.2.1    Market size, by region, 2017 – 2028 (USD Million)

4.3.3    Polysomnography (PSG) device

4.3.3.1    Market size, by region, 2017 – 2028 (USD Million)

4.3.4    Respiratory polygraph

4.3.4.1    Market size, by region, 2017 – 2028 (USD Million)

4.3.5    Sleep screening devices

4.3.5.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 5   Sleep Apnea Devices Market, By End-use

5.1    Key segment trends

5.2    Home Care Settings & Individuals

5.2.1    Market size, by region, 2017 – 2028 (USD Million)

5.3    Sleep Laboratories & Hospitals

5.3.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 6   Sleep Apnea Devices Market, By Region

6.1    Key regional trends

6.2    North America

6.2.1    Market size, by country, 2017 -2028 (USD Million)

6.2.2    Market size, by product, 2017 – 2028 (USD Million)

6.2.2.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.2.2.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.2.3    Market size, by end-use, 2017 – 2028 (USD Million)

6.2.4    U.S.

6.2.4.1    Market size, by product, 2017 – 2028 (USD Million)

6.2.4.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.2.4.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.2.4.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.2.5    Canada

6.2.5.1    Market size, by product, 2017 – 2028 (USD Million)

6.2.5.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.2.5.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.2.5.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.3    Europe

6.3.1    Market size, by country, 2017-2028 (USD Million)

6.3.2    Market size, by product, 2017 – 2028 (USD Million)

6.3.2.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.3.2.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.3.3    Market size, by end-use, 2017 – 2028 (USD Million)

6.3.4    Germany

6.3.4.1    Market size, by product, 2017 – 2028 (USD Million)

6.3.4.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.3.4.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.3.4.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.3.5    UK

6.3.5.1    Market size, by product, 2017 – 2028 (USD Million)

6.3.5.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.3.5.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.3.5.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.3.6    France

6.3.6.1    Market size, by product, 2017 – 2028 (USD Million)

6.3.6.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.3.6.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.3.6.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.3.7    Spain

6.3.7.1    Market size, by product, 2017 – 2028 (USD Million)

6.3.7.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.3.7.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.3.7.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.3.8    Italy

6.3.8.1    Market size, by product, 2017 – 2028 (USD Million)

6.3.8.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.3.8.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.3.8.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.4    Asia Pacific

6.4.1    Market size, by country, 2017 -2028 (USD Million)

6.4.2    Market size, by product, 2017 – 2028 (USD Million)

6.4.2.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.4.2.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.4.3    Market size, by end-use, 2017 – 2028 (USD Million)

6.4.4    China

6.4.4.1    Market size, by product, 2017 – 2028 (USD Million)

6.4.4.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.4.4.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.4.4.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.4.5    Japan

6.4.5.1    Market size, by product, 2017 – 2028 (USD Million)

6.4.5.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.4.5.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.4.5.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.4.6    India

6.4.6.1    Market size, by product, 2017 – 2028 (USD Million)

6.4.6.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.4.6.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.4.6.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.4.7    Australia

6.4.7.1    Market size, by product, 2017 – 2028 (USD Million)

6.4.7.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.4.7.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.4.7.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.4.8    South Korea

6.4.8.1    Market size, by product, 2017 – 2028 (USD Million)

6.4.8.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.4.8.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.4.8.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.5    Latin America

6.5.1    Market size, by country, 2017 -2028 (USD Million)

6.5.2    Market size, by product, 2017 – 2028 (USD Million)

6.5.2.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.5.2.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.5.3    Market size, by end-use, 2017 – 2028 (USD Million)

6.5.4    Brazil

6.5.4.1    Market size, by product, 2017 – 2028 (USD Million)

6.5.4.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.5.4.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.5.4.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.5.5    Mexico

6.5.5.1    Market size, by product, 2017 – 2028 (USD Million)

6.5.5.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.5.5.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.5.5.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.5.6    Argentina

6.5.6.1    Market size, by product, 2017 – 2028 (USD Million)

6.5.6.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.5.6.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.5.6.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.6    MEA

6.6.1    Market size, by country, 2017 -2028 (USD Million)

6.6.2    Market size, by product, 2017 – 2028 (USD Million)

6.6.2.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.6.2.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.6.3    Market size, by end-use, 2017 – 2028 (USD Million)

6.6.4    South Africa

6.6.4.1    Market size, by product, 2017 – 2028 (USD Million)

6.6.4.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.6.4.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.6.4.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.6.5    Saudi Arabia

6.6.5.1    Market size, by product, 2017 – 2028 (USD Million)

6.6.5.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.6.5.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.6.5.2    Market size, by end-use, 2017 – 2028 (USD Million)

6.6.6    UAE

6.6.6.1    Market size, by product, 2017 – 2028 (USD Million)

6.6.6.1.1    Market size, by therapeutics, 2017 – 2028 (USD Million)

6.6.6.1.2    Market size, by diagnostics, 2017 – 2028 (USD Million)

6.6.6.2    Market size, by end-use, 2017 – 2028 (USD Million)

Chapter 7   Company Profiles

7.1    Competitive dashboard, 2021

7.2    BMC Medical Co., Ltd.

7.2.1    Business overview

7.2.2    Financial data

7.2.3    Product landscape

7.2.4    Strategic outlook

7.2.5    SWOT analysis

7.3    LivaNova PLC

7.3.1    Business overview

7.3.2    Financial data

7.3.3    Product landscape

7.3.4    Strategic outlook

7.3.5    SWOT analysis

7.4    Cadwell Laboratories Inc.

7.4.1    Business overview

7.4.2    Financial data

7.4.3    Product landscape

7.4.4    Strategic outlook

7.4.5    SWOT analysis

7.5    Fisher & Paykel Healthcare

7.5.1    Business overview

7.5.2    Financial data

7.5.3    Product landscape

7.5.4    Strategic outlook

7.5.5    SWOT analysis

7.6    Invacare Corporation

7.6.1    Business overview

7.6.2    Financial data

7.6.3    Product landscape

7.6.4    Strategic outlook

7.6.5    SWOT analysis

7.7    Itamar Medical Ltd

7.7.1    Business overview

7.7.2    Financial data

7.7.3    Product landscape

7.7.4    Strategic outlook

7.7.5    SWOT analysis

7.8    Natus Medical Inc.

7.8.1    Business overview

7.8.2    Financial data

7.8.3    Product landscape

7.8.4    Strategic outlook

7.8.5    SWOT analysis

7.9    Nihon Kohden

7.9.1    Business overview

7.9.2    Financial data

7.9.3    Product landscape

7.9.4    Strategic outlook

7.9.5    SWOT analysis

7.10    Koninklijke Philips N.V.

7.10.1    Business overview

7.10.2    Financial data

7.10.3    Product landscape

7.10.4    Strategic outlook

7.10.5    SWOT analysis

7.11    ResMed Inc.

7.11.1    Business overview

7.11.2    Financial data

7.11.3    Product landscape

7.11.4    Strategic outlook

7.11.5    SWOT analysis

7.12    Teleflex Inc.

7.12.1    Business overview

7.12.2    Financial data

7.12.3    Product landscape

7.12.4    Strategic outlook

7.12.5    SWOT analysis

7.13    Drive DeVilbiss International (Drive Medical)

7.13.1    Business overview

7.13.2    Financial data

7.13.3    Product landscape

7.13.4    Strategic outlook

7.13.5    SWOT analysis

7.14    WEINMANN Emergency Medical Technology GmbH + Co. KG

7.14.1    Business overview

7.14.2    Financial data

7.14.3    Product landscape

7.14.4    Strategic outlook

7.14.5    SWOT analysis

Data Tables

TABLE 1.    Global sleep apnea devices industry 3600 synopsis 2017-2028

TABLE 2.    Global sleep apnea devices market, 2017 – 2021 (USD Million)

TABLE 3.    Global sleep apnea devices market, 2022 – 2028 (USD Million)

TABLE 4.    Global sleep apnea devices market, by product, 2017 – 2021 (USD Million)

TABLE 5.    Global sleep apnea devices market, by product, 2022 – 2028 (USD Million)

TABLE 6.    Global sleep apnea devices market, by end-use, 2017 – 2021 (USD Million)

TABLE 7.    Global sleep apnea devices market, by end-use, 2022 – 2028 (USD Million)

TABLE 8.    Global sleep apnea devices market, by region, 2017 – 2021 (USD Million)

TABLE 9.    Global sleep apnea devices market, by region, 2022 – 2028 (USD Million)

TABLE 10.    Industry impact forces

TABLE 11.    Therapeutics market size, by region, 2017 – 2021 (USD Million)

TABLE 12.    Therapeutics market size, by region, 2022 – 2028 (USD Million)

TABLE 13.    Airway clearance systems market size, by region, 2017 – 2021 (USD Million)

TABLE 14.    Airway clearance systems market size, by region, 2022 – 2028 (USD Million)

TABLE 15.    Adaptive servo-ventilation (ASV) market size, by region, 2017 – 2021 (USD Million)

TABLE 16.    Adaptive servo-ventilation (ASV) market size, by region, 2022 – 2028 (USD Million)

TABLE 17.    Positive airway pressure (PAP) device market size, by region, 2017 – 2021 (USD Million)

TABLE 18.    Positive airway pressure (PAP) device market size, by region, 2022 – 2028 (USD Million)

TABLE 19.    Oral appliances market size, by region, 2017 – 2021 (USD Million)

TABLE 20.    Oral appliances market size, by region, 2022 – 2028 (USD Million)

TABLE 21.    Oxygen devices market size, by region, 2017 – 2021 (USD Million)

TABLE 22.    Oxygen devices market size, by region, 2022 – 2028 (USD Million)

TABLE 23.    Others market size, by region, 2017 – 2021 (USD Million)

TABLE 24.    Others market size, by region, 2022 – 2028 (USD Million)

TABLE 25.    Diagnostics market size, by region, 2017 – 2021 (USD Million)

TABLE 26.    Diagnostics market size, by region, 2022 – 2028 (USD Million)

TABLE 27.    Actigraphy systems market size, by region, 2017 – 2021 (USD Million)

TABLE 28.    Actigraphy systems market size, by region, 2022 – 2028 (USD Million)

TABLE 29.    Polysomnography (PSG) device market size, by region, 2017 – 2021 (USD Million)

TABLE 30.    Polysomnography (PSG) device market size, by region, 2022 – 2028 (USD Million)

TABLE 31.    Respiratory polygraph market size, by region, 2017 – 2021 (USD Million)

TABLE 32.    Respiratory polygraph market size, by region, 2022 – 2028 (USD Million)

TABLE 33.    Sleep screening devices market size, by region, 2017 – 2021 (USD Million)

TABLE 34.    Sleep screening devices market size, by region, 2022 – 2028 (USD Million)

TABLE 35.    Home care settings & individuals market size, by region, 2017 – 2021 (USD Million)

TABLE 36.    Home care settings & individuals market size, by region, 2022 – 2028 (USD Million)

TABLE 37.    Sleep laboratories & hospitals market size, by region, 2017 – 2021 (USD Million)

TABLE 38.    Sleep laboratories & hospitals market size, by region, 2022 – 2028 (USD Million)

TABLE 39.    North America sleep apnea devices market size, by country, 2017 – 2021 (USD Million)

TABLE 40.    North America sleep apnea devices market size, by country, 2022 – 2028 (USD Million)

TABLE 41.    North America sleep apnea devices market size, by product, 2017 – 2021 (USD Million)

TABLE 42.    North America sleep apnea devices market size, by product, 2022 – 2028 (USD Million)

TABLE 43.    North America sleep apnea devices market size, by therapeutics, 2017 – 2021 (USD Million)

TABLE 44.    North America sleep apnea devices market size, by therapeutics, 2022 – 2028 (USD Million)

TABLE 45.    North America sleep apnea devices market size, by diagnostics, 2017 – 2021 (USD Million)

TABLE 46.    North America sleep apnea devices market size, by diagnostics, 2022 – 2028 (USD Million)

TABLE 47.    North America sleep apnea devices market size, by end-use, 2017 – 2021 (USD Million)

TABLE 48.    North America sleep apnea devices market size, by end-use, 2022 – 2028 (USD Million)

TABLE 49.    U.S. sleep apnea devices market size, by product, 2017 – 2021 (USD Million)

TABLE 50.    U.S. sleep apnea devices market size, by product, 2022 – 2028 (USD Million)

TABLE 51.    U.S. sleep apnea devices market size, by therapeutics, 2017 – 2021 (USD Million)

TABLE 52.    U.S. sleep apnea devices market size, by therapeutics, 2022 – 2028 (USD Million)

TABLE 53.    U.S. sleep apnea devices market size, by diagnostics, 2017 – 2021 (USD Million)

TABLE 54.    U.S. sleep apnea devices market size, by diagnostics, 2022 – 2028 (USD Million)

TABLE 55.    U.S. sleep apnea devices market size, by end-use, 2017 – 2021 (USD Million)

TABLE 56.    U.S. sleep apnea devices market size, by end-use, 2022 – 2028 (USD Million)

TABLE 57.    Canada sleep apnea devices market size, by product, 2017 – 2021 (USD Million)

TABLE 58.    Canada sleep apnea devices market size, by product, 2022 – 2028 (USD Million)

TABLE 59.    Canada sleep apnea devices market size, by therapeutics, 2017 – 2021 (USD Million)

TABLE 60.    Canada sleep apnea devices market size, by therapeutics, 2022 – 2028 (USD Million)

TABLE 61.    Canada sleep apnea devices market size, by diagnostics, 2017 – 2021 (USD Million)

TABLE 62.    Canada sleep apnea devices market size, by diagnostics, 2022 – 2028 (USD Million)

TABLE 63.    Canada sleep apnea devices market size, by end-use, 2017 – 2021 (USD Million)

TABLE 64.    Canada sleep apnea devices market size, by end-use, 2022 – 2028 (USD Million)

TABLE 65.    Europe sleep apnea devices market size, by country, 2017 – 2021 (USD Million)

TABLE 66.    Europe sleep apnea devices market size, by country, 2022 – 2028 (USD Million)

TABLE 67.    Europe sleep apnea devices market size, by product, 2017 – 2021 (USD Million)

TABLE 68.    Europe sleep apnea devices market size, by product, 2022 – 2028 (USD Million)

TABLE 69.    Europe sleep apnea devices market size, by therapeutics, 2017 – 2021 (USD Million)

TABLE 70.    Europe sleep apnea devices market size, by therapeutics, 2022 – 2028 (USD Million)

TABLE 71.    Europe sleep apnea devices market size, by diagnostics, 2017 – 2021 (USD Million)

TABLE 72.    Europe sleep apnea devices market size, by diagnostics, 2022 – 2028 (USD Million)

TABLE 73.    Europe sleep apnea devices market size, by end-use, 2017 – 2021 (USD Million)

TABLE 74.    Europe sleep apnea devices market size, by end-use, 2022 – 2028 (USD Million)

TABLE 75.    Germany sleep apnea devices market size, by product, 2017 – 2021 (USD Million)

TABLE 76.    Germany sleep apnea devices market size, by product, 2022 – 2028 (USD Million)

TABLE 77.    Germany sleep apnea devices market size, by therapeutics, 2017 – 2021 (USD Million)

TABLE 78.    Germany sleep apnea devices market size, by therapeutics, 2022 – 2028 (USD Million)

TABLE 79.    Germany sleep apnea devices market size, by diagnostics, 2017 – 2021 (USD Million)

TABLE 80.    Germany sleep apnea devices market size, by diagnostics, 2022 – 2028 (USD Million)

TABLE 81.    Germany sleep apnea devices market size, by end-use, 2017 – 2021 (USD Million)

TABLE 82.    Germany sleep apnea devices market size, by end-use, 2022 – 2028 (USD Million)

TABLE 83.    UK sleep apnea devices market size, by product, 2017 – 2021 (USD Million)

TABLE 84.    UK sleep apnea devices market size, by product, 2022 – 2028 (USD Million)

TABLE 85.    UK sleep apnea devices market size, by therapeutics, 2017 – 2021 (USD Million)

TABLE 86.    UK sleep apnea devices market size, by therapeutics, 2022 – 2028 (USD Million)

TABLE 87.    UK sleep apnea devices market size, by diagnostics, 2017 – 2021 (USD Million)

TABLE 88.    UK sleep apnea devices market size, by diagnostics, 2022 – 2028 (USD Million)

TABLE 89.    UK sleep apnea devices market size, by end-use, 2017 – 2021 (USD Million)

TABLE 90.    UK sleep apnea devices market size, by end-use, 2022 – 2028 (USD Million)

TABLE 91.    France sleep apnea devices market size, by product, 2017 – 2021 (USD Million)

TABLE 92.    France sleep apnea devices market size, by product, 2022 – 2028 (USD Million)

TABLE 93.    France sleep apnea devices market size, by therapeutics, 2017 – 2021 (USD Million)

TABLE 94.    France sleep apnea devices market size, by therapeutics, 2022 – 2028 (USD Million)

TABLE 95.    France sleep apnea devices market size, by diagnostics, 2017 – 2021 (USD Million)

TABLE 96.    France sleep apnea devices market size, by diagnostics, 2022 – 2028 (USD Million)

TABLE 97.    France sleep apnea devices market size, by end-use, 2017 – 2021 (USD Million)

TABLE 98.    France sleep apnea devices market size, by end-use, 2022 – 2028 (USD Million)

TABLE 99.    Spain sleep apnea devices market size, by product, 2017 – 2021 (USD Million)

TABLE 100.    Spain sleep apnea devices market size, by product, 2022 – 2028 (USD Million)

TABLE 101.    Spain sleep apnea devices market size, by therapeutics, 2017 – 2021 (USD Million)

TABLE 102.    Spain sleep apnea devices market size, by therapeutics, 2022 –

By Product

  • Therapeutics
    • Airway Clearance Systems
    • Adaptive Servo-ventilation (ASV)
    • Positive Airway Pressure (PAP) Device
    • Oral Appliances
    • Oxygen Devices
    • Others
  • Diagnostics
    • Actigraphy Systems
    • Polysomnography (PSG) Device
    • Respiratory Polygraph
    • Sleep Screening Devices

By End-use

  • Home Care Settings & Individuals
  • Sleep Laboratories & Hospitals

 

Koninklijke Philips N.V., Fisher & Paykel Healthcare, ResMed Inc., Invacare Corporation, Natus Medical Inc., and Teleflex Inc., among others.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF